Chromadex Corp (NASDAQ: CDXC) Drops -26.02% From Highs, What Happens Next?

Chromadex Corp (NASDAQ:CDXC)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 1.93. At the close of trading, the stock’s price was $3.69, to imply a decrease of -2.64% or -$0.1 in intraday trading. The CDXC share’s 52-week high remains $4.65, putting it -26.02% down since that peak but still an impressive 66.12% since price per share fell to its 52-week low of $1.25. The company has a valuation of $277.89M, with an average of 293.41K shares over the past 3 months.

Chromadex Corp (NASDAQ:CDXC) trade information

After registering a -2.64% downside in the last session, Chromadex Corp (CDXC) has traded red over the past five days. The stock hit a weekly high of 4.18, dropping -2.64% in its intraday price action. The 5-day price performance for the stock is -4.16%, and 20.59% over 30 days. With these gigs, the year-to-date price performance is 158.04%.

Chromadex Corp (CDXC) estimates and forecasts

Looking at statistics comparing Chromadex Corp share performance against respective industry, we note that the company has outperformed competitors. Chromadex Corp (CDXC) shares are 184.94% up over the last 6 months, with its year-to-date growth rate higher than industry average at 71.43% against 13.30%. Revenue is forecast to grow 33.30% this quarter before jumping 66.70% for the next one. The rating firms project that company’s revenue will grow 16.80% compared to the previous financial year.

Revenue forecast for the current quarter as set by 3 analysts is $23.97 million. Meanwhile, for the quarter ending Jun 2024, a total of 3 analyst(s) estimate revenue growth to $23.84 million.Earnings reports from the last fiscal year show that sales brought in $22.56 million and -$ respectively in the corresponding quarters.

CDXC Dividends

Chromadex Corp has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Chromadex Corp has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.